Combination of antibiotic and nucleic acid binding compound for bacterial antibiotic resistance
CA 2367149 C · Owner: Howard M. Shapiro, M.D. P.C. · Inventors: Shapiro, Howard M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is drawn to methods of killing bacteria including , antibiotic resistant bacteria by contacting said bacteria with a membrane permeabilizing compound or combination of compounds and a membrane impermeant toxic agent or combination of agents, resulting in the death of the bacteria without substantial injury to the infected host or patient. The present invention is further drawn to compositions and kits for effecting the method of the present invention. The present invention is further drawn to methods of rendering toxic agents such as toxic organic molecules membrane impermeant , for use in the methods and compositions of the present invention.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 21, 2000 and granted September 20, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 21, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 21, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.